Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus placebo in elderly patients with generalized anxiety disorder
2009-010902-13Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of duloxetine in generalized anxiety disorder (GAD) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change in Hamilton Anxiety Rating Scale total score. Started May 2010; status: completed.
02
Drugs
duloxetine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2009-010902-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010902-13.